LIVZON PHARMA (01513): Tian Qiusheng and Huang Jinhua Resign as Independent Non-Executive Directors

Stock News
2025/10/14

LIVZON PHARMA (01513) announced that the Board of Directors recently received written resignation letters from independent non-executive directors Mr. Tian Qiusheng and Mr. Huang Jinhua. Both Mr. Tian Qiusheng and Mr. Huang Jinhua have served as independent non-executive directors of the company since October 15, 2019, and by October 15, 2025, they will have served continuously as independent non-executive directors for six years. According to the "Administrative Measures for Independent Directors of Listed Companies" and the "Articles of Association," among other relevant regulations, independent directors may not serve for more than six consecutive years. Therefore, Mr. Tian Qiusheng and Mr. Huang Jinhua submitted written resignation letters to the Board of Directors. Mr. Tian Qiusheng has applied to resign from his positions as independent non-executive director of the company's eleventh Board of Directors, member of the Audit Committee, chairman of the Remuneration and Assessment Committee, member of the Nomination Committee, and member of the Environmental, Social and Governance Committee. Mr. Huang Jinhua has applied to resign from his position as member of the Environmental, Social and Governance Committee. To ensure the normal operation of the Board of Directors, before new independent non-executive directors are elected at the company's shareholders' meeting, Mr. Tian Qiusheng and Mr. Huang Jinhua will continue to fulfill their respective responsibilities as independent non-executive directors and members of various specialized committees of the Board of Directors in accordance with the "Articles of Association," "Administrative Measures for Independent Directors of Listed Companies," "Hong Kong Listing Rules," and other relevant regulations.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10